Company intelligence / Profile preview

Gansu Puankang Pharmaceutical

Lanzhou City, Gansu Province, Chinagspazy.com ↗

Ownership: Private
Development stage: Commercial

Overview

Gansu Puankang Pharmaceutical is the only corporation in China authorized to produce and sell medicinal poppy products. The company operates at a commercial scale, supplying pharmaceutical-grade opiate alkaloids for use in pain management and anesthesia. It plays a critical role in the national supply chain for these controlled substances[10].

Therapeutic areas: OtherNeurology
Modalities: Small moleculePlant-derived product
Industry: Chemicals & Materials

Drug pipeline

1 asset

xuanfeizhisou

Commercial

Indications: Respiratory diseases

Partnerships

Not specified; as a state-authorized supplier of controlled substances in China, it likely works closely with government agencies[10].

Beyond the preview

Go deeper on Gansu Puankang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gansu Puankang Pharmaceutical.

Explore the full profile